Reports
Reports
The endoscope reprocessing market is an essential element within the healthcare ecosystem as it provides organized processes for high-level disinfection and sterilization of endoscopy instruments that allow safe reuse.
As endoscopy keeps becoming a larger part of diagnostics and minimally invasive surgery as utilized by an increasing range of specialties, including gastroenterology, pulmonology, urology, and gynecology, the endoscope reprocessing industry has seen a significant increase in demand to deliver a competent, efficient, and competent reprocessing solution for hospitals, ambulatory surgical centers, and special clinics to reuse endoscopes safely and following regulations to prevent infection.
These processes include a range of automated endoscope reprocessors (AERs), chemical disinfectants or detergent, drying cabinets, storage cabinets, tracking systems, as well as systems that will allow the endoscopes to continue working as intended.
The rise in global awareness associated with infection control, especially in the wake of hospital-acquired or healthcare-associated infections (HAIs), has led to increased dependability on these systems through ensuring consistency, standardization and accurate tracking of endoscopy instruments and the processes of reprocessing endoscopes.
The other factors contributing to the increased demand for a reliable and standardized reprocessing platform are the continuing and significant increasing investments in healthcare infrastructure, as well as innovation within the global healthcare market and the introduction of the digital design for traceability and compliance.
The innovation will turn traditional and semi-regulated reprocessing in workflow to a highly regulated and competitive reprocessing system. There are numerous companies and key players in the market that have extended product offerings to provide all in the same product to ensure quality, reliance on a preferred sterilizer company, traceability (more for business), and compliance with local, state, national, and international regulators.
Rising adoption of minimally invasive procedures (MIPs) (especially endoscopic procedures) at the global level is one of the primary reasons for the endoscope reprocessing market growth. MIPs are increasingly preferred by patients due to shorter recovery times, minimal surgical trauma, and reduced stays in the hospital.
Both - flexible and rigid endoscopes are critical for performing diagnostic and therapeutic procedures, and with the inclusion of MIPs, the rate of usage of endoscopes has increased substantially-meaning there is a strong demand for effective and safe reprocessing solutions to health care providers.
For example, the American Society for Gastrointestinal Endoscopy (ASGE) estimates that more than 20 million gastrointestinal endoscopies are performed in the U.S. every year.
This means that for every endoscopic procedure there is a requirement that the endoscope must be thoroughly reprocessed using appropriate reprocessing methods to prevent cross-contamination and in order to meet infection control requirements. Given this significant increase in endoscopic procedures, the demand for effective, automated, standardized, and high-throughput reprocessing systems is heightened in healthcare settings.
Further, the increasing number of outpatient care centers along with rapid growth of day-care surgical units around the globe means that there is a faster turnaround for reprocessed endoscopes.
Another major factor driving growth of the endoscope reprocessing market is the emphasis on infection control by global regulatory agencies. For example, the U.S. Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), European Centre for Disease Prevention and Control (ECDC), and Japan's Ministry of Health have websites (and public statements) that discuss endoscope reprocessing policies, and the necessity of adhering to guidelines is aimed at reducing healthcare-associated infections (HAIs), particularly those associated with multidrug-resistant organisms.
Regulatory agencies will continue to amend their guidelines to account for new and emerging threats and technology changes; for example, the agencies are encouraging the use of automated endoscope reprocessors (AERs) and traceability.
Following multiple outbreaks of duodenoscope infections in hospitals in the U.S., the FDA has made safety communications about reprocessing that recommended the addition of manufacturer recommended reprocessing steps, microbiological surveillance and, redesign of some equipment.
As a consequence of the emphasis from regulatory agencies and ramifications for HAIs, hospitals and clinics are investing in the compliance endoscope reprocessing technology that includes automated systems, validated disinfectants, leak tests, and digital tracking. Hospitals are implementing safer methods and products in addition to protecting themselves from fines for noncompliance and of course reputation effects.
North America is the leading base for the global endoscope reprocessing markets, largely due to the United States. The region's position is attributed to a developed healthcare system, high volume of procedures, and strict regulation requiring infection prevention. Hospitals and ambulatory surgery centers in the United States complete a significant volume of endoscopic procedures every year, demanding reliable and effective reprocessing systems to provide safety and compliance.
In addition to the volume, guidelines have been published by health authorities including the Food and Drug Administration (FDA), the Centers for Medicare & Medicaid Services (CMS), and the Centers for Disease Control and Prevention (CDC) that dictate the proper cleaning, disinfection and sterilization of endoscopic instruments. These regulations act to drive the adoption of new automated reprocessors, detergents of standardization, and digital monitoring systems that provide improved traceability and less manual error.
In addition, the presence of top manufacturers including STERIS, Olympus Corp. of the Americas and Getinge AB, with strong distribution networks, and R&D division to strengthen the U.S. market. Lastly, the significant growth in investments in outpatient care and the ongoing focus on infection prevention related to healthcare service provide definitive aspect to the market position.
NA
NA
NA
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Endoscope Reprocessing Market
